Fox Chase patients may be eligible to receive third COVID-19 vaccine dose – Read More

MENU

Liane McCarroll, MS, CCC-SLP/L

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111

About

Assistant Research Professor
Senior Speech Pathologist
Fox Chase Cancer Center
Department of Otolaryngology-Head & Neck Surgery, Lewis Katz School of Medicine, Temple University

Specialties

Treatment Focus

Oral Cancer; Laryngeal and Hypopharyngeal Cancers; Oropharyngeal Cancer

 
  • Specialized skills include Videofluoroscopic Swallowing Studies, Fiberoptic Endoscopic Examination of Swallowing, Video Stroboscopy, and alaryngeal communication including management of Tracheo-esophageal Punctures (TEP). 
  • Also works in the Multidisciplinary Voice and Swallow Clinic. She is an advisor to “The SpeakEezy Club for larngectomees" and “The Head and Neck Cancer Support Group” at Fox Chase Cancer Center.
Education and Training

Educational Background

  • MS, Speech-Language Pathology, LaSalle University, Philadelphia, PA, 2010
  • BS, Speech-Language-Hearing Science, LaSalle University, Philadelphia, PA, 2009

Certifications

  • STAR Certified - Survivorship Training and Rehabilitation
  • MBSImP Registered Clinician

Memberships

  • American Speech Language and Hearing Association (ASHA)
  • ASHA Special Interest Group 03 - Voice and Voice Disorders
  • ASHA Special Interest Group 13 - Swallowing and Swallowing Disorders
  • International Association of Laryngectomee's (IAL)
Research Profile

Research Interests

  • Dysphagia
  • Dysphonia
  • Head and Neck Cancer Rehabilitation
  • Survivorship
Publications

Selected Publications

Book Chapters:

McCarroll L, Ebersole B. The role of voice therapy in managing laryngopharyngeal reflux. In Jamal N, Wang M, eds: Laryngopharyngeal Reflux Disease: Integrative Approaches. Philadelphia, PA: Springer Nature, SPi Global publishers; 2018 IN PRESS.

Published Articles:

Sulibhavi, A., Tharmalingam, S., McCarroll, L., Soliman, A. Reversible bevacizumab induced vocal fold necrosis. Journal of Voice 2020 Dec 21: S0892-1997(20)30431-8. doi: 10.1016/j.jvoice.2020.11.028. Epub ahead of print. PMID: 33358072.

Ebersole, B., McCarroll, L., Ridge J., Liu, J., Bauman, J., Donnelly, S., Galloway, T. Identification and Management of Late Dysfunction in Survivors of Head and Neck Cancer: Implementation and Outcomes of an Interdisciplinary Quality of Life (IQOL) Clinic. Head and Neck. 2021; 1-12. https://doi.org/10.1002/hed.26681.

Accepted Abstracts - Oral Presentations:

Sulibhavi, A, Tharmalingam, S, McCarroll, L, Soliman, A. “Reversible Bevacizumab-Induced Vocal Fold Necrosis”. Oral presentation at Virtual Annual Meeting of the Pennsylvania Academy of Otolaryngology June 13th, 2020.

Ebersole B, McCarroll L, Lango M, Ridge J, Liu J, Schmalbach C. Dysphagia Following Total Laryngectomy: When to treat with dysphagia therapy? A case study. Oral Presentation. 2019 Head and Neck Cancer Survivorship Symposium, Pittsburgh, PA. August 5-6 2019.

Connect with Fox Chase